Bio Vaxys Technology Corp. announced it raised $249,000 in an initial filing from an offering of $249,000
Bio Vaxys Technology Corp. announced it raised $249,000 in an initial filing from an offering of $249,000
09/22/21, 6:29 PM
Location
Money raised
$249,000
Industry
therapeutics
health care
biotechnology
Round Type
pre-seed
Company Info
Location
503 - 905 west pender street
etobicoke, ontario, canada
Additional Info
BioVaxys Technology Corp. (CSE:BIOV, OTCQB:BVAXF, FR:5LB), formerly BioVaxys LLC, is a British Columbia-registered clinical-stage biotechnology company dedicated to improving patient lives with novel immunotherapies based on our DPX™ immune-educating delivery technology platform and our HapTenix© neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields.